Icarus Unburned

Icarus is not a story about the limitations of humanity.
It is a story about the limitations of wax.

/*
 
    Foxtrot Sigma-9 Theme
    [2022 Wikidot Theme]
    By Liryn
 
*/
 
/* FONTS */
 
@import url('https://fonts.bunny.net/css2?family=Montserrat:ital,wght@0,800;1,800&display=swap');
 
@import url('https://fonts.bunny.net/css2?family=Lexend:wght@700;800&display=swap');
 
@import url('https://fonts.bunny.net/css2?family=JetBrains+Mono:ital,wght@0,400;0,700;1,400;1,700&display=swap');
 
@import url('https://fonts.bunny.net/css2?family=Fira+Code:wght@400;700&display=swap');
 
@import url('https://fonts.bunny.net/css2?family=Sofia+Sans:ital,wght@0,400;0,700;1,400;1,700&display=swap');
 
@import url('https://scp-wiki.wikidot.com/local--files/theme:foxtrot/inter.css');
 
@import url('https://fonts.bunny.net/css2?family=Figtree:wght@800;900&display=swap');
 
@import url('https://fonts.bunny.net/css2?family=IBM+Plex+Sans:ital,wght@0,400;0,500;0,600;0,700;1,400;1,500;1,600;1,700&display=swap');
 
/* VARIABLES */
 
:root {
 
    /* VARIABLES > Core */
 
    --header-title: "SCP Foundation";
    --header-subtitle: "SECURE, CONTAIN, PROTECT";
    --logo-img: url(https://scp-wiki.wikidot.com/local--files/theme:foxtrot/fxtrt-scp_logo_lightmode.svg);
    --darkmode-logo-img: url(https://scp-wiki.wikidot.com/local--files/theme:foxtrot/fxtrt-scp_logo_darkmode.svg);
    --logo-opacity: 14%;
 
    --head-font: 'Sans Normalcy';
    --ui-font: 'IBM Plex Sans';
    --mono-font: 'JetBrains Mono', 'Fira Code', monospace;
    --page-font: 'Inter', 'verdana';
    --base-font-size: 0.9rem;
    --page-font-size: 1rem;
 
    /* VARIABLES > Misc */
 
    --header-txt-color: #333333;
    --subheader-txt-color: rgb(var(--accent));
    --misc-txt-color: #464646;
    --link-txt-color: #E6283C;
    --link-hover-txt-color: white;
 
    /* VARIABLES > Color Accents */
 
    --accent: var(--acc-default);
 
    --acc-default: 59, 59, 59;
    --acc-wyoming: 142, 0, 18;
    --acc-canada: var(--acc-default);
    --acc-poland: 87, 44, 17;
    --acc-slothspit: 27, 60, 133;
    --acc-vanguard: 0, 153, 75;
    --acc-threshold: 121, 113, 130;
    --acc-overwatch: 28, 37, 56;
    --acc-spc: 0, 165, 200;
    --acc-fishing: 67, 111, 145;
    --acc-nightfall: 151, 0, 2;
    --acc-hybrasil: 27, 60, 133;
    --acc-goc: 39, 84, 149;
    --acc-spooky: 252, 112, 40;
 
    /* VARIABLES > BetterFootnotes */
 
    --fnColor: var(--link-txt-color);
    --fnLinger: 1s;
 
}
 
/* VARIABLES > Info Bar */
 
.info-container {
    --barColour: rgb(var(--accent));
    --linkColour: #EDEDED;
}
 
/* MAIN */
 
html {
    scroll-behavior: smooth;
    overflow-x: hidden;
}
 
body {
    font-family: var(--ui-font), sans-serif;
    font-size: var(--base-font-size);
    color: rgb(51, 51, 51);
    background-image: linear-gradient(to bottom, #e0e0e0, #fff 200px);
    text-rendering: optimizeLegibility;
    overflow-wrap: break-word;
}
 
div#container-wrap {
    background: none;
}
 
#content-wrap {
    margin: 2em auto 0;
}
 
#page-content {
    font-family: var(--page-font), var(--ui-font), sans-serif;
    font-size: var(--page-font-size);
    font-weight: 440;
}
 
#page-content strong {
    font-weight: 700;
}
 
tt,
.page-source,
pre,
#edit-page-textarea {
    font-family: var(--mono-font);
}
 
ol li {
    margin: 0 0 1em;
}
 
ul {
    margin: 1em 0;
}
 
li,
p {
    line-height: 1.5;
    text-underline-offset: 40%;
}
 
::selection {
    background: rgb(var(--accent));
    color: #fff;
}
 
/* Clicky links */
a,
a.newpage,
a:visited,
#side-bar a:visited {
    color: var(--link-txt-color);
}
 
a:hover,
a.newpage:hover,
a:visited:hover,
#side-bar a:visited:hover {
    color: var(--link-hover-txt-color);
    text-decoration: none;
    background-color: var(--link-txt-color);
}
 
a {
    transition-duration: 0.1s;
}
 
/* patch for sidebar media, collapsibles, ACS, info button and ayers module so link doesn't override */
#page-content .collapsible-block-folded a:hover,
#page-content .collapsible-block-unfolded-link a:hover,
#page-content .rate-box-with-credit-button .fa-info:hover,
#side-bar .side-block.media a:hover,
.danger-diamond a:hover {
    background: transparent;
}
 
.info-container .collapsible-block-folded .collapsible-block-link,
.info-container .collapsible-block-link {
    background: var(--linkColour) !important;
}
 
/* MAIN > Header */
 
div#header {
    background: none;
    height: 160px;
}
 
#header h1 span,
#header h2 span {
    font-size: 0;
    display: none;
}
 
#header h1 a::before,
#header h2::before {
    color: var(--header-txt-color);
    letter-spacing: 1px;
    font-family: var(--head-font), sans-serif !important;
    font-weight: 900;
    text-shadow: none;
}
 
#header h1 {
    margin-top: -0.3rem;
}
 
#header h1 a {
    width: fit-content;
    margin: auto;
}
 
#header h1 a::before {
    content: var(--header-title);
    font-size: 1.3em;
}
 
#header h2::before {
    content: var(--header-subtitle);
    font-family: var(--ui-font) !important;
    font-weight: 700;
    font-size: 1.4em;
    color: var(--misc-txt-color);
    line-height: 26px;
    margin-top: 0.35rem;
    display: block;
    text-transform: uppercase;
}
 
#header h1,
#header h2 {
    margin-left: 0;
    float: none;
    text-align: center;
}
 
#header h1 span,
#header h2 span {
    font-size: 0;
    display: none;
}
 
div#extra-div-1 {
    height: 160px;
    width: 100%;
    top: 7px;
    position: absolute;
    background: var(--logo-img) 10px 30px no-repeat;
    background-size: 130px;
    background-repeat: no-repeat;
    background-position: 50% 50%;
    z-index: -1;
    opacity: var(--logo-opacity);
}
 
/* MAIN > Header > Search Box */
 
#search-top-box-form>input[type=text] {
    display: none;
}
 
#search-top-box-input,
#search-top-box-input:hover,
#search-top-box-input:focus,
#search-top-box-form input[type=submit],
#search-top-box-form input[type=submit]:hover,
#search-top-box-form input[type=submit]:focus {
    border: none;
    background: rgb(var(--accent));
    box-shadow: none;
    border-radius: 5px !important;
    color: #efefef;
    font-family: var(--ui-font);
    font-size: calc(var(--page-font-size) - 10%);
}
 
#search-top-box input.empty {
    color: #999999;
}
 
#search-top-box {
    position: absolute;
    top: 47px;
    width: unset;
}
 
/* MAIN > Header > Top Bar */
 
#top-bar,
#top-bar a {
    top: 10rem;
}
 
#header #top-bar ul {
    border-radius: 10px;
    border: none;
    background: rgb(var(--accent));
    padding-left: 15px;
    padding-right: 15px;
}
 
#header #top-bar a {
    color: white;
    background: rgb(var(--accent));
    font-weight: bold;
}
 
#header #top-bar ul li ul {
    padding: 0px;
    border-radius: 0px;
}
 
#top-bar ul li.sfhover a,
#top-bar ul li:hover a {
    border-left: solid 1px #FFF;
    border-right: solid 1px #FFF;
}
 
#top-bar ul li ul li a:hover {
    color: rgba(255, 255, 255, 0.83) !important;
    line-height: 230%;
    text-indent: 3px;
}
 
#top-bar {
    display: flex;
    justify-content: center;
    right: 0;
}
 
.mobile-top-bar {
    left: unset;
}
 
/* MAIN > Header > Login Info */
 
#login-status {
    top: 19px;
}
 
#login-status,
#login-status a {
    color: #333333;
}
 
@media (max-width: 767px) {
    #header .printuser {
        font-size: 0;
    }
}
 
.printuser a {
    margin: 0;
}
 
.printuser img.small {
    width: 18px;
    height: 18px;
    padding: 1px 4px 0 0;
 
    background-image: none !important;
}
 
@media (max-width: 767px) {
    #header .printuser img.small {
        transform: translate(0, 4px);
    }
}
 
#my-account {
    display: none;
}
 
@media (max-width: 767px) {
    #account-topbutton {
        margin: 0 0 0 5px;
    }
}
 
/* MAIN > Header > Side Bar */
 
#top-bar .open-menu a {
    border-radius: 0px;
    border: none;
    background: rgb(var(--accent));
    color: white;
}
 
#side-bar {
    background: #FFF;
}
 
@media (min-width: 768px) {
 
    #side-bar {
        padding: 0.3em 0.6em 0 0.6em;
        width: 18.75em;
        transition: left 0.2s ease-in-out;
        direction: rtl;
        text-align: left;
        border-right: none;
    }
 
}
 
#side-bar .side-block,
#side-bar .side-block.resources,
#side-bar .side-block.media,
#interwiki .side-block {
    border: 2px solid rgba(0, 0, 0, 0.2);
    border-radius: 0px;
    box-shadow: none;
    margin-bottom: 6px;
    direction: ltr;
    background: transparent;
}
 
#side-bar .side-block.resources {
    text-align: center;
}
 
#side-bar .heading {
    color: var(--misc-txt-color);
    border-bottom: solid 2px #cfcfcf;
    font-size: 9pt;
    font-family: var(--head-font);
    font-weight: 800;
    text-transform: uppercase;
}
 
/* CONTENT */
 
/* CONTENT > Blockquotes, Custom Divs */
 
.blockquote,
div.blockquote,
blockquote {
    border: solid 2px rgba(0, 0, 0, 0.15);
    background: #f7f7f7;
}
 
.jotting {
    padding: 1.3em;
    margin: 1em 4.5em;
    border: dashed 2px rgba(0, 0, 0, 0.2);
    background: #f7f7f7;
}
 
.notation {
    padding: 1em 1.5em;
    margin: 1em 3em;
    border-left: solid 3px rgba(0, 0, 0, 0.35);
    border-right: solid 3px rgba(0, 0, 0, 0.35);
    background: #f7f7f7;
}
 
.modal {
    padding: 1.2em;
    margin: 1em 3em;
    border: solid 5px rgba(0, 0, 0, 0.15);
    background: #fbfbfb;
}
 
.quote {
    padding: 0.4em 2em;
    margin: 3em auto;
    border-left: solid 3px #bbb;
    max-width: 500px !important;
}
 
.paper {
    padding: 1.5em;
    margin: 2em;
    background: #FFF;
    box-shadow: 0px 4px 9px rgba(0, 0, 0, 0.2);
}
 
.box {
    padding: 1px 9px;
    border: solid 3px #bbb;
    margin: 0.5em 1em;
}
 
div.note {
    font-size: unset;
    border: 2px solid #afafaf;
    background-color: #fff;
}
 
.round {
    border-radius: 10px;
}
 
/* CONTENT > Headings, Titles */
 
#page-title,
.meta-title {
    font-family: var(--ui-font), sans-serif;
    font-weight: 800;
    color: #3b3b3b;
    border-bottom: solid 2px rgba(0, 0, 0, 0.2);
    width: fit-content;
    margin: 0 auto 1.5rem;
}
 
#page-title,
.meta-title,
#breadcrumbs,
.pseudocrumbs {
    text-align: center;
}
 
h1,
h2,
h3,
h4,
h5,
h6 {
    font-family: var(--head-font), sans-serif;
    font-weight: 800;
    color: #3b3b3b;
}
 
h1,
h2 {
    font-weight: 800;
}
 
.footnotes-footer .title {
    font-family: var(--head-font), sans-serif;
    color: #3b3b3b;
    font-weight: 800;
}
 
/* CONTENT > Rate Module */
 
#page-content .creditRate {
    margin: unset;
    font-family: var(--ui-font);
    float: unset !important;
}
 
#page-content .rate-box-with-credit-button {
    background-color: #fff;
    border: solid 1px #bbb;
    box-shadow: none;
    border-radius: 0;
}
 
#page-content .rate-box-with-credit-button .fa-info {
    border: none;
    color: #333;
}
 
#page-content .rate-box-with-credit-button .fa-info:hover {
    background: #333;
    color: #fff;
}
 
.rate-box-with-credit-button .cancel {
    border: solid 1px #fff;
}
 
.page-rate-widget-box {
    box-shadow: none;
    border: solid 1px #bbb;
    margin: unset;
    margin-bottom: 4px;
    border-radius: 0;
    font-family: var(--ui-font);
}
 
.page-rate-widget-box .rate-points {
    background-color: #fff !important;
    color: #333 !important;
    border: none !important;
    border-radius: 0;
}
 
.page-rate-widget-box .rateup,
.page-rate-widget-box .ratedown {
    background-color: #fff;
    border-top: none;
    border-bottom: none;
}
 
.page-rate-widget-box .rateup a,
.page-rate-widget-box .ratedown a {
    background: transparent;
    color: #333;
}
 
.page-rate-widget-box .rateup a:hover,
.page-rate-widget-box .ratedown a:hover {
    background: #333;
    color: #fff;
}
 
.page-rate-widget-box .cancel {
    background: #fff;
    border: none;
    border-radius: 0;
    display: inline-block;
}
 
.page-rate-widget-box .cancel a {
    color: #333;
}
 
.page-rate-widget-box .cancel a:hover {
    background: #333;
    color: #fff;
    border-radius: 0;
}
 
#page-content .rate-box-with-credit-button .page-rate-widget-box {
    border: none;
}
 
/* CONTENT > Rate Module > Author Label */
 
.authorlink-wrapper {
    --author-top-adjust: 0;
    --author-bottom-adjust: 0;
    --author-right-adjust: 0;
    font-family: var(--ui-font);
    font-size: var(--base-font-size);
}
 
/* CONTENT > Side Box */
 
.anchor {
    position: sticky;
    height: 0;
    top: 0;
}
 
.sidebox {
    padding: .14rem;
    margin-top: 0;
    margin-bottom: 8px;
    width: calc((100vw - 870px)/2);
    max-height: calc(100vh - 18rem);
    position: absolute;
    top: 0;
    left: 103.5%;
    z-index: 5;
    overflow: auto;
    box-sizing: border-box;
}
 
@media (max-width: 1290px) {
    .sidebox {
        display: none;
        visibility: hidden;
    }
}
 
/* CONTENT > Image Block */
 
.scp-image-block .scp-image-caption {
    background-color: #f4f4f4;
    color: #3b3b3b;
    border: solid 2px rgba(0, 0, 0, 0.1);
    margin-top: 8px;
    box-sizing: border-box;
    border-radius: 4px;
}
 
.scp-image-block {
    border: none;
    box-shadow: none;
}
 
.scp-image-block img {
    border: solid 2px rgba(0, 0, 0, 0.1);
    box-sizing: border-box;
}
 
.imagediv {
    float: right;
    margin: 15px
}
 
@media (max-width: 540px) {
    .imagediv {
        float: unset;
        text-align: center;
        margin: 1.3rem auto 1.3rem auto;
    }
}
 
@media only screen and (max-width: 600px) {
    .scp-image-block.block-right {
        float: none;
        margin: 10px auto;
    }
}
 
/* CONTENT > Tables Base */
 
#page-content tr th {
    padding: 6px;
    border: 2px solid rgba(0, 0, 0, 0.2);
}
 
#page-content tr td {
    padding: 12px;
    border: 2px solid #bfbfbf;
    line-height: 1.4;
}
 
#page-content .sidebox tr td,
#page-content .sidebox tr th {
    padding: 0.35em;
}
 
/* CONTENT > Tables Customization (Table Coloring System) */
 
/* CONTENT > Tables Customization (Table Coloring System) > Table Headings, Image Captions */
 
#page-content .table1 tr th,
#page-content .table1 .scp-image-block .scp-image-caption {
    background-color: #E0FFD4;
}
 
#page-content .table2 tr th,
#page-content .table2 .scp-image-block .scp-image-caption {
    background-color: #D8ECF4;
}
 
#page-content .table3 tr th,
#page-content .table3 .scp-image-block .scp-image-caption {
    background-color: #FDF6D7;
}
 
#page-content .table4 tr th,
#page-content .table4 .scp-image-block .scp-image-caption {
    background-color: #FFDFCD;
}
 
#page-content .table5 tr th,
#page-content .table5 .scp-image-block .scp-image-caption {
    background-color: #FFCFCF;
}
 
#page-content .table6 tr th,
#page-content .table6 .scp-image-block .scp-image-caption {
    background-color: rgba(146, 0, 255, 0.2);
}
 
.tableb .wiki-content-table {
    border-collapse: separate;
    border-spacing: 2px;
}
 
/* CONTENT > Tables Customization (Table Coloring System) > Other Colored Divs */
 
.table1 .blockquote,
.table1 div.blockquote,
.table1 blockquote,
.table1 .jotting,
.table1 .notation,
.table1 .modal,
.table1 .paper,
.blockquote.table1,
div.blockquote.table1,
.jotting.table1,
.notation.table1,
.modal.table1,
.paper.table1 {
    background: rgb(224, 255, 212);
}
 
.table2 .blockquote,
.table2 div.blockquote,
.table2 blockquote,
.table2 .jotting,
.table2 .notation,
.table2 .modal,
.table2 .paper,
.blockquote.table2,
div.blockquote.table2,
.jotting.table2,
.notation.table2,
.modal.table2,
.paper.table2 {
    background: rgb(226, 244, 255);
}
 
.table3 .blockquote,
.table3 div.blockquote,
.table3 blockquote,
.table3 .jotting,
.table3 .notation,
.table3 .modal,
.table3 .paper,
.blockquote.table3,
div.blockquote.table3,
.jotting.table3,
.notation.table3,
.modal.table3,
.paper.table3 {
    background: rgb(255, 245, 189);
}
 
.table4 .blockquote,
.table4 div.blockquote,
.table4 blockquote,
.table4 .jotting,
.table4 .notation,
.table4 .modal,
.table4 .paper,
.blockquote.table4,
div.blockquote.table4,
.jotting.table4,
.notation.table4,
.modal.table4,
.paper.table4 {
    background: rgb(255, 223, 205);
}
 
.table5 .blockquote,
.table5 div.blockquote,
.table5 blockquote,
.table5 .jotting,
.table5 .notation,
.table5 .modal,
.table5 .paper,
.blockquote.table5,
div.blockquote.table5,
.jotting.table5,
.notation.table5,
.modal.table5,
.paper.table5 {
    background: rgb(255, 207, 207);
}
 
.table6 .blockquote,
.table6 div.blockquote,
.table6 blockquote,
.table6 .jotting,
.table6 .notation,
.table6 .modal,
.table6 .paper,
.blockquote.table6,
div.blockquote.table6,
.jotting.table6,
.notation.table6,
.modal.table6,
.paper.table6 {
    background: rgb(255, 218, 255);
}
 
/* CONTENT > Tabs Base */
 
.yui-navset .yui-nav a,
.yui-navset .yui-navset-top .yui-nav a {
    background-color: inherit;
    background-image: inherit
}
 
.yui-navset .yui-nav a:hover,
.yui-navset .yui-nav a:focus {
    background: inherit;
    text-decoration: inherit
}
 
.yui-navset .yui-nav .selected a,
.yui-navset .yui-nav .selected a:focus,
.yui-navset .yui-nav .selected a:hover {
    color: inherit;
    background: inherit
}
 
.yui-navset .yui-nav,
.yui-navset .yui-navset-top .yui-nav {
    border-color: inherit
}
 
.yui-navset li {
    line-height: inherit
}
 
/* CONTENT > Tabs Customization */
 
.yui-navset .yui-nav,
.yui-navset .yui-navset-top .yui-nav {
    display: flex;
    flex-wrap: wrap;
    width: calc(100% - .125rem);
    margin: 0 auto;
    border-color: #333333;
    box-shadow: none;
}
 
.yui-navset .yui-nav a,
/* ---- Link Modifier ---- */
.yui-navset .yui-navset-top .yui-nav a {
    color: #333333;
    /* ---- Tab Background Colour | [UNSELECTED] ---- */
    background-color: #efefef;
    border: unset;
    box-shadow: none;
    box-shadow: none;
}
 
.yui-navset .yui-nav a:hover,
.yui-navset .yui-nav a:focus {
    color: #ffffff;
    /* ---- Tab Background Colour | [HOVER] ---- */
    background-color: #333333;
}
 
.yui-navset .yui-nav li,
/* ---- Listitem Modifier ---- */
.yui-navset .yui-navset-top .yui-nav li {
    position: relative;
    display: flex;
    flex-grow: 2;
    max-width: 100%;
    margin: 0;
    padding: 0;
    color: #ffffff;
    background-color: #ffffff;
    border-color: transparent;
    box-shadow: none;
}
 
.yui-navset .yui-nav li a,
.yui-navset-top .yui-nav li a,
.yui-navset-bottom .yui-nav li a {
    display: flex;
    align-items: center;
    justify-content: center;
    width: 100%;
}
 
.yui-navset .yui-nav li em {
    border: unset;
}
 
.yui-navset .yui-nav a em,
.yui-navset .yui-navset-top .yui-nav a em {
    padding: .35em .75em;
 
    text-overflow: ellipsis;
    overflow: hidden;
    white-space: nowrap;
}
 
.yui-navset .yui-nav .selected,
/* ---- Selection Modifier ---- */
.yui-navset .yui-navset-top .yui-nav .selected {
    flex-grow: 2;
    margin: 0;
    padding: 0;
    /* ---- Tab Background Colour | [SELECTED] ---- */
    background-color: #333333;
}
 
.yui-navset .yui-nav .selected a,
.yui-navset .yui-nav .selected a em {
    border: none;
}
 
.yui-navset .yui-nav .selected a {
    width: 100%;
    color: #ffffff;
}
 
.yui-navset .yui-nav .selected a:focus,
.yui-navset .yui-nav .selected a:active {
    color: #ffffff;
    background-color: #333333;
}
 
.yui-navset .yui-content {
    background-color: #ffffff;
    box-shadow: none;
}
 
.yui-navset .yui-content,
.yui-navset .yui-navset-top .yui-content {
    padding: .5em;
    border: 1px solid #333;
    box-sizing: border-box;
}
 
/* CONTENT > WORDS NO BROKEY. CROQ HAS SPOKEY. and other things */
 
span,
a {
    word-break: normal !important
}
 
.avatar-hover {
    display: none !important;
}
 
#main-content .page-tags span {
    max-width: 100%;
}
 
/* CONTENT > Dustjacket Assets */
 
.fancyhr hr {
    border-top: 2vw solid transparent;
    background-color: rgba(var(--bright-accent), 0);
    height: 0;
    box-sizing: border-box;
    border-image-source: url('https://scp-wiki.wikidot.com/local--files/theme:foxtrot/wl_hr.webp');
    border-image-repeat: round round;
    background: none;
    border-image-slice: 80 500 80 500 fill;
    border-image-width: 10em 80em 10em 80em;
}
 
.fancyborder {
    box-sizing: border-box;
    border: 2vw solid rgba(0, 0, 0, 0.5);
    border-image: url('https://scp-wiki.wikidot.com/local--files/theme:foxtrot/wl_border.webp') 600 round;
    border-image-width: 6;
    padding: 2vw;
}
 
/* CONTENT > Collapsibles */
 
#page-content a.collapsible-block-link:hover {
    text-decoration: underline;
    color: var(--link-txt-color);
}
 
#page-content a.collapsible-block-link:not(.licensebox a.collapsible-block-link, .info-container a.collapsible-block-link, .default-col a.collapsible-block-link) {
    text-decoration: none;
    font-weight: bold;
    color: white;
    padding-top: 4px;
    padding-bottom: 4px;
    padding-left: 7px;
    padding-right: 9px;
    background: rgb(var(--accent));
    border-radius: 6px;
    margin-top: 5px;
    font-family: var(--ui-font);
    font-size: var(--base-font-size);
    box-shadow: inset 0px 0px 0px 2px rgba(0, 0, 0, 0.4);
    transition-duration: 0.4s;
    display: inline-block;
 
}
 
#page-content a.collapsible-block-link:not(.licensebox a.collapsible-block-link, .info-container a.collapsible-block-link, .default-col a.collapsible-block-link):hover {
    background: rgba(var(--accent), 0.7);
    box-shadow: none;
}
 
/* CONTENT > ACS Adjustments */
 
.top-left-box>.item {
    display: none;
}
 
.anom-bar-container {
    margin-top: 1.1rem;
}
 
.anom-bar-container,
.anom-bar-container * {
    font-family: var(--ui-font), Inter, sans-serif !important;
}
 
.acs-extra-1,
.acs-extra-2,
.acs-extra-3,
.acs-extra-4 {
    font-family: var(--ui-font), Inter, sans-serif !important;
}
 
.anom-bar > .top-box {
    text-transform: none;
}
 
/* CONTENT > Woed Bar Adjustments */
 
div.scale div.item1>div {
    color: #333;
    font-family: var(--head-font);
    font-size: 1.4em;
    text-transform: uppercase;
    letter-spacing: 2px;
    line-height: unset;
}
 
div.scale div.class1>div {
    color: #333;
    font-family: var(--head-font);
    font-size: 2em;
    line-height: 0.9em;
    letter-spacing: 2px;
}
 
div.scale {
    --woedbar-class-bar-color: #333 !important;
}
 
div.scale div.obj {
    height: 1.7em;
}
 
div.scale div.obj>div {
    font-size: 1.55em;
}
 
/* MISC */
 
#page-content hr {
    height: 2px;
}
 
.bt {
    color: rgb(var(--accent));
    font-weight: bold;
}
 
#footer {
    background: transparent;
    color: #444;
    margin-top: 45px;
}
 
#footer a {
    color: #7b7b7b;
}
 
.footer-wikiwalk-nav {
    font-weight: 700;
    font-size: 88%;
    word-spacing: 5px;
}
 
#page-info-break {
    height: 10px;
}
 
#page-options-container {
    border-top: solid 1px rgba(213, 213, 213, 0.5);
    padding-top: 1rem;
}
 
.page-watch-options {
    padding-bottom: 0.6rem;
    font-size: 77%;
}
 
.page-options-bottom {
    display: flex;
    flex-direction: row;
    flex-wrap: wrap;
    align-content: center;
    justify-content: center;
}
 
.page-options-bottom a {
    margin: 3px;
    color: #FFF;
    background: rgb(var(--accent));
    padding: 5px 13px 5px 13px;
    text-decoration: none;
    font-size: 90%;
    border-bottom-left-radius: 4px;
    border-bottom-right-radius: 4px;
}
 
.page-options-bottom a:hover {
    background: rgba(var(--accent), 0.8);
}
 
#page-info-break {
    height: 6px;
}
 
#license-area {
    color: #5f5f5f;
    background: #ecf2f1;
    border-top: solid 2px #d9d9d9;
    margin-top: 10px;
}
 
#license-area a::after {
    content: ".";
}
 
@media (min-width: 768px) {
    #main-content .page-tags {
        padding-right: 16rem;
    }
}
 
#main-content div.page-tags::before {
    content: "tags   ";
    color: var(--misc-txt-color);
    font-family: var(--head-font);
    font-weight: 800;
    font-size: var(--page-font-size);
}
 
#main-content .page-tags a {
    display: inline-block;
    height: .8125rem;
    margin: 0 0 .5rem .75rem;
    padding: .1875rem .3125rem .1875rem 0;
    color: #FFF;
    background-color: rgb(var(--accent));
    border-bottom-right-radius: .25rem;
    border-top-right-radius: .25rem;
    line-height: 13px;
    line-height: .8125rem;
    font-size: calc(var(--page-font-size) - 10%);
    font-weight: bold;
}
 
#main-content .page-tags a::before {
    width: 0;
    height: 0;
    top: -.1875rem;
    left: -.625rem;
    padding: 0 .0625rem .1875rem;
    border-color: transparent rgb(var(--accent)) transparent transparent;
    border-style: solid;
    border-width: .5rem .5rem .5rem 0;
}
 
#main-content .page-tags a::before,
#main-content .page-tags a::after {
    content: "";
    position: relative;
    float: left;
}
 
#main-content .page-tags a::after {
    width: .25rem;
    height: .25rem;
    top: .2813rem;
    left: -.5rem;
    background-color: #FFF;
    border-radius: .125rem;
}
 
#main-content .page-tags span {
    max-width: 100%;
    border-top: .5rem solid transparent;
}
 
#page-tags-input {
    font-weight: bold;
    word-spacing: 8px;
}
 
#edit-page-form input.text {
    font-family: var(--head-font), sans-serif;
    font-weight: 800;
    font-size: 150% !important;
    padding: 4px;
}
 
#edit-page-form>table.form>tbody>tr>td:nth-child(1) {
    font-weight: bold;
}
 
.edit-help-34 {
    font-size: 85%;
    opacity: 60%;
    transition-duration: 0.3s;
    width: fit-content;
}
 
.edit-help-34:hover {
    opacity: 100%;
}
 
.edit-help-34 a {
    margin-right: 3px;
    margin-left: 10px;
}
 
table.edit-page-bottomtable {
    width: 100%;
}
 
#edit-page-comments {
    height: 86px;
}
 
#lock-info {
    background-color: transparent;
    margin: 0.8em;
    line-height: 1.7;
    font-size: 86%;
    border: none;
}
 
#lock-info::before {
    content: "!";
    padding-right: 12px;
    font-weight: bold;
    font-size: 110%;
    opacity: 60%;
}
 
#lock-timer {
    font-size: 115%;
    margin: 0 5px;
}
 
#lock-timer::before {
    content: "⏲ ";
    opacity: 80%;
}
 
textarea,
#edit-page-form input.text {
    outline: none;
    border: 1px solid #ccc;
    transition-duration: 0.3s;
    transition-property: box-shadow;
}
 
textarea:focus-visible,
#edit-page-form input.text:focus-visible {
    box-shadow: 0px 0px 0px 1px #a3a3a3;
    border: 1px solid #a3a3a3;
}
 
#action-area>p {
    font-size: 85%;
    color: darkslategrey;
}
 
#action-area>p:nth-child(5)>a {
    display: block;
    text-align: center;
    font-size: 120%;
    font-weight: bold;
}
 
#who-rated-page-area>div {
    column-count: 4;
}
 
@media (max-width: 900px) {
    #who-rated-page-area>div {
        column-count: 3;
    }
}
 
@media (max-width: 700px) {
    #who-rated-page-area>div {
        column-count: 2;
    }
}
 
@media (max-width: 540px) {
    #who-rated-page-area>div {
        column-count: 1;
    }
}
 
#page-content .content-warning.creditRate {
    padding-top: 8px;
    padding-right: 21px;
}
 
.preview-message {
    right: 0em;
    top: 2em;
    border: unset;
    padding: 1em 1.5em;
    background-color: rgba(0, 0, 0, 0.9);
    max-width: 29em;
    opacity: 1;
    z-index: 100;
    line-height: 1.7;
    filter: drop-shadow(0px 0px 4px rgba(0, 0, 0, 0.2));
    color: #EDEDED;
}
 
.error-block {
    background-color: rgba(255, 0, 48, 0.1);
    text-align: center;
    border: none;
    border-top: solid 3px #B00;
    border-top-left-radius: 6px;
    border-top-right-radius: 6px;
}
 
table.page-history tbody tr:nth-child(2n) {
    background: rgba(var(--accent), 0.05);
}
 
.owindow {
    animation: fade 0.5s;
}
 
@keyframes fade {
    0% {
        opacity: 0;
    }
 
    100% {
        opacity: 1;
    }
}
 
.owindow .button-bar a {
    border: solid 2px rgba(0, 0, 0, 0.1);
    margin: 11px;
    padding: 0.5em 2em;
    border-radius: 4px;
}
 
.owindow .button-bar a:hover {
    background-color: var(--link-txt-color);
    color: var(--link-hover-txt-color);
    border-radius: 0px;
}
 
.owindow .button-bar {
    padding: 1.2em 1em 1.2em;
}
 
.owindow .table {
    margin-bottom: 1.5rem;
}
 
.owindow .title {
    cursor: default;
    font-family: var(--head-font);
    font-weight: 800;
    font-size: 155%;
    text-align: center;
    padding: 0.5em 1em;
    border-bottom: solid 2px rgba(187, 187, 187, 0.4);
    background-color: #F7F7F7;
}
 
.owindow.owait .content {
    padding: 0.5em 0.5em 2em;
    background-image: none;
}
 
.owindow.owait .content::after {
    content: " ";
    display: block;
    width: 1.5rem;
    height: 1.5rem;
    margin: -0.9rem auto;
    margin-top: 1rem;
    animation: loading 1.2s linear infinite;
    border-top: 0.4rem solid grey;
    border-right: 0.4rem solid transparent;
    border-bottom: 0.4rem solid grey;
    border-left: 0.4rem solid transparent;
    border-radius: 50%;
}
 
@keyframes loading {
    0% {
        transform: rotate(0deg);
    }
 
    100% {
        transform: rotate(360deg);
    }
}
 
.owindow.osuccess {
    padding: 0.5em;
}
 
.owindow div.content:nth-child(2)>img:nth-child(1) {
    margin-right: 1.2rem;
    margin-top: 1rem;
}
 
.odialog-shader {
    background-color: #262a39;
}
 
.btn {
    transition-duration: 0.15s;
}
 
.btn:not(#main-content .btn, #search-top-box-form input[type="submit"]),
.btn.btn-primary,
div.buttons input,
input.button:not(#search-top-box-form input[type="submit"]) {
    padding: 0.5em;
    margin: 11px;
    border-radius: 3px;
    font-family: var(--ui-font);
    cursor: pointer;
}
 
#edit-cancel-button,
#edit-diff-button,
#edit-preview-button,
#edit-save-draft-button,
#edit-save-continue-button,
#edit-save-button {
    background: #fff;
    border: solid 1px #ccc;
    cursor: pointer;
    font-family: var(--ui-font);
    color: #333;
    padding: 0.5rem 14px;
    margin: 1px;
    font-size: 90%;
    border-radius: 3px;
}
 
#edit-cancel-button:hover,
#edit-diff-button:hover,
#edit-preview-button:hover,
#edit-save-draft-button:hover,
#edit-save-continue-button:hover,
#edit-save-button:hover {
    background-color: #eaeaea;
}
 
#edit-save-continue-button,
#edit-save-button {
    background: #dbffd6;
    transition-duration: 0.3s;
    color: #005a0a;
}
 
#edit-save-continue-button:hover,
#edit-save-button:hover {
    color: #fff;
    background: #0d951c;
}
 
#edit-cancel-button {
    background: #ffe1e1;
    transition-duration: 0.3s;
    color: #c52727;
}
 
#edit-cancel-button:hover {
    color: #fff;
    background: #c5272e;
}
 
table.page-history tbody tr {
    color: #757575;
}
 
.fncon {
    font-size: var(--page-font-size) !important;
    line-height: 1.4;
    border: 2px solid rgba(0, 0, 0, 0.2);
}
 
.fncon::before {
    font-size: var(--page-font-size) !important;
}
 
.hovertip {
    border: none !important;
    box-shadow: 0px 0px 4px rgba(0, 0, 0, 0.2);
    background: #FFF;
    padding: 3px;
    max-width: 400px;
}
 
input.checkbox,
.page-history input,
#h-perpage {
    cursor: pointer;
}
 
input,
textarea {
    font-family: var(--ui-font);
}
 
#breadcrumbs,
.pseudocrumbs {
    font-weight: bold;
    font-size: 110%;
    font-family: var(--ui-font);
}
 
/* ---- REDUCED MOTION ACCESSIBILITY ---- */
@media (prefers-reduced-motion: reduce) {
 
    *,
    *::before,
    *::after {
        animation-duration: .001s !important;
        animation-iteration-count: 1 !important;
        transition-duration: .001s !important;
    }
}
 
/* @MEDIA */
 
@media (max-width: 850px) {
 
    #header h2::before {
        font-size: 1.4em;
    }
 
}
 
@media (max-width: 700px) {
 
    #header h2::before {
        font-size: 1.2em;
        margin-top: 0.3rem;
    }
 
    #top-bar,
    #top-bar a {
        top: 8.8rem;
        font-size: 90%;
    }
 
}
 
@media (max-width: 620px) {
 
    #header h2::before {
        font-size: 1em;
        margin-top: 0.15rem;
    }
 
    #top-bar,
    #top-bar a {
        top: 8.3rem;
        font-size: 90%;
    }
 
    div#header {
        height: 123px;
    }
 
}
 
@media (max-width: 520px) {
 
    #header h2::before {
        line-height: 16px;
        margin-top: 0.5rem;
    }
 
    #top-bar,
    #top-bar a {
        top: 9.3rem;
    }
 
    div#header {
        height: 145px;
    }
 
}
rating: +61+x
From Dr. Simon Torres
Subject Project Asclepius
To ics.suipelcsA|LLA#ics.suipelcsA|LLA

All right, everyone, this is a global push. If anyone here has been living inside VNP-3001 for the last few months, the PENTAGRAM made a highly communicable virus that permanently seals all magical potential of almost all living creatures. mRNA and other dynamic vaccines seem ineffective here, so don't expect this to be as easy as curing malaria or HIV.

This is our top priority; if your project has anything to do with thaumaturgy or biochemistry, your project is being suspended to work on this effective immediately. Everyone else, your access to priority resources has been deprioritized.

We have a year to fix this mess that the US government caused. Let's show the world what the global scientific community can do.

We will not go back to dying in the dark.

Simon Torres, CEO of Phoenix Technologies
Icarus is not a story about the limitations of humanity
It is a story about the limitations of wax.

From Dr. Laurent
Subject Re:Project Asclepius
To Dr. Simon Torres

What is the budget for this?

Dr. Laurent: Director of Phoenix Thaumic Biochemistry
Where humanity failed, science must succeed

From Dr. Simon Torres
Subject Re:RE:Project Asclepius
To Dr. Laurent

Whatever is needed.

Simon Torres, CEO of Phoenix Technologies
Icarus is not a story about the limitations of humanity
It is a story about the limitations of wax.


Fox News

foxnews.com

Breaking: One Nation Under Quarantine.

"Total violation of American sovereignty" according to President Crenshaw.


From Dr. Laurent: Director of Phoenix Thaumic Biochemistry
Subject Analysis of the virus
To ics.suipelcsA|SISYLANA#ics.suipelcsA|SISYLANA

The PENTAGRAM and JOICL are not cooperating at all in how they made this thing, so it looks like we need to reverse-engineer it. Attached is the genetic sequence of the virus's RNA and the predicted proteome, complete with structures. The fact that this thing can infect so many different organisms is at least an advantage, as there are almost certainly no post-transcriptional modifications that are not encoded into the virus. Normal viruses tend to only target one species, which allows them to modify enzymes using processes built into the host cell.

The problem is that this is the largest human virus I have ever seen at 300 thousand base pairs and there is significant usage on nontranslational and possibly anomalous base pairs as well.

Dr. Laurent: Director of Phoenix Thaumic Biochemistry
Where humanity failed, science must succeed


3 Attachments:

From Dr. Eisenberg
Subject Mechanism of thaumic action
To ics.suipelcsA|SISYLANA#ics.suipelcsA|SISYLANA

From a thaumic perspective, this looks to be ingenious, the virus seems to have figured out how to synthesize scrantonite-353. For people who do not work in thaumic engineering, scrantonite is very effective at shutting down local magic due to the relativistic motion of quarks inside the Nuclei. See Scrantonite Symmetrization of the Mill Field, Dr. Cyprog, 1989 Prometheus Publishing.

The one good decision these guys made was using scrantonite-353 as opposed to the much more stable scrantonite-354 used in SRAs and advanced thaumic shielding. So at least the antimagic effect will be constrained in the person affected. However, this also means slow radiation poisoning and some good old-fashioned heavy metal poisoning in the long run.

Dr. Eisenberg
Professor of Ontological Studies, Swiss Federal Institute of Technology
Applied linear algebra isn't magic. Magic is applied linear algebra.

From Dr. Hansen
Subject Basic analysis
To ics.suipelcsA|SISYLANA#ics.suipelcsA|SISYLANA

This virus has a very odd structure. It is a negative-strand RNA virus that acts as both a traditional virus and as a retrovirus. I am unsure how this virus creates scrantonite other than that it requires significant amounts of local EVE, however, the DNA reverse transcriptases are scrantonite-activated while the RNA polymerases are scrantonite-inactivated.

Effectively the Virus replicates rapidly like the flu in the early stages and tries to produce scrantonite, if it can produce scrantonite with local EVE quantities, then it integrates into the DNA of cells to continue to produce scrantonite.

Dr. Hansen: Doctor of virology, Cambridge University

From Dr. Tinad
Subject The perfect anti-vaccine measure
To ics.suipelcsA|SISYLANA#ics.suipelcsA|SISYLANA

Bingo! We figured out why we cannot use regular vaccinations against this virus. Normal vaccinations work by providing examples of spike proteins to the body. The immune system then makes antibodies against said spike proteins and remembers how to make them.

The thing is that something about this virus's coating is antimemetic on a cellular level and the immune system cannot 'remember' how to fight it. The folks in medical are currently trying large numbers of recombinant sequences for mRNA vaccines, but we are uncertain that would work.

Dr. Tinad: Caltech Department of Antimemetics

From Dr. Aquevist
Subject Novel Scrantonite Synthesis pathway
To ics.suipelcsA|SISYLANA#ics.suipelcsA|SISYLANA

Enzyme 27 has been fully identified and we think we found how this thing is making scrantonite. It is alchemically transmuting a mixture of nitrogen, iron, and cobalt into scrantonite. Now this normally requires a full-on transmutation circle.

We have designated it as Mal-EVE.

Based on our simulations, the people making this did a fantastic job. They figured out how to use the natural vibrations for the enzyme to act as a form of somatic component for the ritual to create the scrantonite. I have attached a video with the "atomic hands" highlighted.

Dr. Aquevist, University of Copenhagen


1 Attachment:


Financial Times

Carter Courier Channel now operational, restarting the flow of essential goods


From Dr. Laurent
Subject Mechanisms of the Virus.
To ics.suipelcsA|llA#ics.suipelcsA|llA

Now, as per the attached paper, we can safely say that we have a good grasp of the virus and how it works. Now let's see ideas here on how we can stop this virus. I want to hear as many ideas about this as we can. Traditional methods have failed, so let's see what the brain trust can think of.

Dr. Laurent: Director of Phoenix Thaumic Biochemistry
Where humanity failed, science must succeed


1 Attachment:

From Dr. Andrews
Subject re:Mechanisms of the Virus
To Dr. Laurent

Well, we know that traditional mRNA vaccines don't work because of the antimemetic structure of its spike proteins. High throughput mutational analysis has not found a related structure without this property, so most of the traditional methods will not work here. mRNA, weakened virus, viral fragment, and Mnemosyne Fluid injections are all out the window here.

Sherry Andrews PhD, Director Office of Immunological Anomalies and Research
Vanguard, Lighthouse-234.
Punching pathogens in the face since gods knows when.

From Dr. Laurent
Subject re:re:Mechanisms of the Virus
To ics.suipelcsA|ERUC#ics.suipelcsA|ERUC

Could we develop a form of mnestics that could counteract that?

Dr. Laurent: Director of Phoenix Thaumic Biochemistry
Where humanity failed, science must succeed

From Dr. Tinad
Subject re:re:re:Mechanisms of the Virus
To ics.suipelcsA|SISYLANA#ics.suipelcsA|SISYLANA

We are working on it.

Dr. Tinad: Caltech Department of Antimemetics


From Dr. Leep Andrews
Subject Project Warlock's Wheel
To ics.suipelcsA|ERUC#ics.suipelcsA|ERUC

Something we have seen is people in high Hume environments, like the Rocky Mountains, seem to have a slightly lower rate of uptake of this virus. As we know the virus's retrovirus phase is activated by scrantonite which in turn requires available EVE. In areas where EVE is naturally suppressed, like high hume areas, we see that the scrantonite doesn't build up to a high enough level to trigger the retroviral components.

We think that a powerful anti-magical field can act as a cure if performed before sufficient scrantonite build-up. We are currently conducting animal trials.

Leep Andrews PhD, Director Office of Virological Anomalies and Research
Vanguard, Lighthouse-234.
Viral packing of information into a narrow genome is the peak of efficiency we should all aim for

Vanguard ROMP channel: Lighthouse-234

Sherry: What kind of differences are we looking at here?

Leep: by our numbers its going from 99.9% effective to 99%

Sherry: Wait, is that even statistically significant?

Leep: yep, N = 10,000 in high hume areas alone. millions everywhere else. MOE of 0.2%.

Sherry: Jesus. I need a stiff drink.

Leep: agreed let's put that budget hike to good use

From Dr. Eisenberg
Subject re:Project Warlock's Wheel
To Dr. Sherry Andrews

There are only a handful of American facilities that can support this treatment program, and that includes Paramax. The cost of doing this would be insane on a per-treatment basis.

Dr. Eisenberg
Professor of Ontological Studies, Swiss Federal Institute of Technology
Applied linear algebra isn't magic. Magic is applied linear algebra.

From Dr. Leep Andrews
Subject re:re:Project Warlock's Wheel
To ics.suipelcsA|SISYLANA#ics.suipelcsA|SISYLANA

It's a useful stopgap measure, hopefully, we can make it work for some people.

Leep Andrews PhD, Director Office of Virological Anomalies and Research
Vanguard, Lighthouse-234.
Viral packing of information into a narrow genome is the peak of efficiency we should all aim for

From Dr. Summers
Subject re:re:Project Warlock's Wheel
To Dr. Leep Andrews

I am concerned about who can use it, the costs here are massively higher than what Medicaid and the US public option are willing to pay for. This cure can only really work for the 1%.

Dr. Summers, Department of Healthcare Economics, Harvard University
What is the value of a human life?


From Dr. Small
Subject Project Nevinyrral
To ics.suipelcsA|ERUC#ics.suipelcsA|ERUC

The antimemetic shielding that this virus has seems to be fairly specific. I think that we can create some form of nanobot that can counteract the virus early in its life cycle. We will want to make sure said nanobot is not self-replicating to avoid what happened with Ceres, but such a system can be both deployed via injection and also deployed at a very widespread level.

Dr. Small: Nanoforge, Lichtenstein
Big things are made of many small things

From Dr. Laurent
Subject Re:Nevinyrral
To Dr. Small

The idea is to create a synthetic immune system?

This is one of the more likely proposals to work so far.

Dr. Laurent: Director of Phoenix Thaumic Biochemistry
Where humanity failed, science must succeed


From Dr. Yossarian Leiner
Subject Project Roze-Kattee
To ics.suipelcsA|ERUC#ics.suipelcsA|ERUC

On my annual Pratchett reread an idea struck me. Could we create a god of plague and medicine that would be able to fix this issue? We would need to modify the Rite of Solomon to create a different form of Demiurge and theoretically, such a god could be created, and be able to cure such an illness.

There are a couple of major issues with this, firstly we will need permission from Vanguard and the GOC to know about the details of the Rite of Solomon. In addition, we have zero idea how to control a god. We presume that we can reverse engineer the Rite to figure this out, but it will require serious experimentation.

The final issue is getting people to believe in said god, the faith must be sincere to work, and generating a new religion is not exactly something we can do ethically. Though looking over some old foundation records, we could do it using widespread memetics. This could potentially be considered a crime against humanity, but it might be what is needed. We will be looking into alternatives there that are more ethical.

In a fit of irony it looks like the old Foundation figured out how to do what the PENTAGRAM was hoping for back in the 2010s using said memetics.

Dr. Yossarian Leiner: Tactical Theology, Vanguard, Lighthouse-27
Baruch Shem Kavod Malchuto L'Olam Va'ed

From Medea
Subject Re:Project Roze-Kattee
To Dr. Yossarian Leiner

….

Are you sure you're not still working for the Foundation?

~Medea of Colchis, Vanguard Department of Mythology and Folklore, Lighthouse-212.
'Betrayal is best met with the poisoned cup, the burning flesh, and your agonized screams.'
this signature is currently under review by the Vanguard HR department


From Dr. Wagner
Subject Project Project Piranther
To ics.suipelcsA|ERUC#ics.suipelcsA|ERUC

The issue here is the production of scrantonite. So let's double down on this, frequent injections of some kind of magic-enhancing material could counteract the scrantonite in the bloodstream. Colloidal silver is mostly nontoxic (apart from turning you into a Homestuck troll) and has magical enhancing properties.

Dr. Wagner: Esoteric Materials, Berlin
It would be a scientifically interesting way to die screaming.

From Dr. Smith
Subject re: Project Project Piranther
To ics.suipelcsA|ERUC#ics.suipelcsA|ERUC

Looking over this proposal, silver will not generate the thaumic enhancement we need. The only materials that I can see working here are Beryllium Bronze and Irrlylite. Irrylite is far too expensive here (back-of-the-envelope calculations say that only Ms Darke could afford it), while Beryllium is very toxic and will kill you in a week.

Dr. Smith: Thaumaturgic metallurgy, Pittsburgh

From Dr. Wagner
Subject re:re:Project Project Piranther
To ics.suipelcsA|ERUC#ics.suipelcsA|ERUC

Sigh, well back to the eternal loop of Esoteric Material Engineering. Making new materials with very useful and interesting properties. Then figuring out how to make materials with the same performance without the use of lead or beryllium.

Has biochemical engineering figured out how to make people immune to lead yet?

Dr. Wagner: Esoteric Materials, Berlin
It would be a scientifically interesting way to die screaming.


Washington Post

Democracy Dies in Darkness

Washington July 3rd, 2049

Para-Pandemic

30% of all thaumically active Americans have been infected by the Washington Viron.


From Dr. Yossarian Leiner
Subject Project Roze-Kattee is a bust
To ics.suipelcsA|ERUC#ics.suipelcsA|ERUC

While Vanguard seems interested in project Roze-Kattee the GOC has said that they will not let the Rite of Solomon out into the wild, saying that it is far too dangerous to use. Citing that it could very much be used to also cause the death of all magic, or worse restrict magic into only being used by a select group. While I would say that is better than the death of all magic that we are staring down, it is also understandable.

Dr. Yossarian Leiner: Tactical Theology, Vanguard, Lighthouse-27
Baruch Shem Kavod Malchuto L'Olam Va'ed

From Midnight
Subject Re:Project Roze-Kattee is a bust
To Dr. Yossarian Leiner

This is most likely for the best. Messing with divinity tends to backfire on those who try.

Midnight.
Curiosity stopped keeping track.


Caltech Teams server chatlog:


Tinad: Well good news and bad news on the mnestic project.

Tinad: Good news is that we have something that works. Bad news is that the only formulation that works is the old 2010 version.

Ebbs: It's what I am thinking of, no?

Tinad: Yep, the one that causes pancreatic cancer and hallucinations of a five tentacled monster, killed basically the entirety of the foundation antimemetics division.

Tinad: To make things worse, you need constant doses of the stuff otherwise it's a new shot for you!

Ebbs: Can we fix it?

Tinad: Probably, the issue is that we seem to have lost all data about mnestic development, and literally no one I know can remember anything about it.

Ebbs: Again?


From Dr. Wagner
Subject Unacceptable levels of beryllium leeching in Project Piranther
To ics.suipelcsA|ERUC#ics.suipelcsA|ERUC

With all nanoscopic coatings on the Beryllium Bronze nanoparticles, all have either produced unacceptable levels of beryllium leeching or are highly carcinogenic in some other way. While a coating of 6-thiohexanoic acid does stop all copper leeching into the bloodstream, beryllium ions are small enough to slip out between the surfactant tails.

The layered fullerene approach does stop beryllium leeching, however, the number of layers required and the interface layers between the Beryllium Bronze nanoparticle, the fullerene, and the environment make the nanoparticle far too large to be useful.

Dr. Wagner: Esoteric Materials, Berlin
It would be a scientifically interesting way to die screaming.

From Dr. Wagner
Subject Unacceptable levels of beryllium leeching in Project Piranther
To ics.suipelcsA|ERUC#ics.suipelcsA|ERUC

And where was that cure for lead I was promised?

Dr. Wagner: Esoteric Materials, Berlin
It would be a scientifically interesting way to die screaming.



Washington Post

Democracy Dies in Darkness

Washington May 7th, 2049

Pittsburgh in the dark


From Dr. Small
Subject Project approved
To ics.suipelcsA|LARRYNIVEN#ics.suipelcsA|LARRYNIVEN

Alright, so project Nevinyrral has been tentatively approved as a potential route to a cure. Now how do we do this?

  • How do we make a form of nanobot that can target and kill the virus?
  • How do we manufacture the number of nanobots we need?
  • How do we make these things small enough?
  • How do we make sure that the immune system doesn't murder these things with extreme prejudice?
  • What energy source can these things use?
  • How do we manufacture the number of nanobots we need?!

Dr. Small: Nanoforge, Lichtenstein
Big things are made of many small things


From Dr. Kumar
Subject Detection
To ics.suipelcsA|LARRYNIVEN#ics.suipelcsA|LARRYNIVEN

We have antibodies we can attach to the nanobots, that should work fine for detection, we can hook that into some fairly simple molecular motors and a peroxide injector to engulf the virus and kill it with hydrogen peroxide. This can be done fairly similarly with any kind of energy source and access to oxygen, fairly easy for the bloodstream and external usage.

Dr. Rahul Kumar: NexGen Biosciences, India


From Dr. Visethreach
Subject Power Generation?
To ics.suipelcsA|LARRYNIVEN#ics.suipelcsA|LARRYNIVEN

Now how do we even begin to power this thing?

Dr. Visethreach: Biomechanics Devi-Agri

From Dr. Werh
Subject re:Power Generation?
To ics.suipelcsA|LARRYNIVEN#ics.suipelcsA|LARRYNIVEN

Inside the body we can use a glucose engine as the powerhouse, however in the larger environment we will need some kind of external power source. Sadly there isn't a huge amount of available free energy in the larger environment.

Dr. Werh. Thermobiochemist, Tswarm Inc

From Dr. Liu
Subject re:re:Power Generation?
To ics.suipelcsA|LARRYNIVEN#ics.suipelcsA|LARRYNIVEN

The biochem people are working on a deuterium fusion pulse enzymatic motor which might work here, based on the old HELL's HEART work.

Dr. Liu: Huo Hua Inc

From Dr. Fleischmann
Subject We can't do magic here
To ics.suipelcsA|LARRYNIVEN#ics.suipelcsA|LARRYNIVEN

Hey "biochem people" here, the fusion pulse enzyme is currently in an extreme prototype stage, and it currently only produces electrical energy, not the chemical energy that this system will need.

Dr. Fleischmann, Biofuse.

From Dr. Small
Subject Well time to pull a rabbit out of a hat
To ics.suipelcsA|LARRYNIVEN#ics.suipelcsA|LARRYNIVEN

Looks like you have a new project then.

Dr. Small: Nanoforge, Lichtenstein
Big things are made of many small things


From Dr. Subramaniam
Subject Shielding the nanobot
To ics.suipelcsA|LARRYNIVEN#ics.suipelcsA|LARRYNIVEN

Alright, how do we stop this thing from getting murdered by the immune system?

Dr. Subramaniam, YHIgen

From Dr. Visethreach
Subject re:Shielding the nanobot
To ics.suipelcsA|LARRYNIVEN#ics.suipelcsA|LARRYNIVEN

A coating of calcium fluorapatite should work to stop the immune system from targeting the nanobot, this will also act as a fairly effective shell around the nanobot.

Dr. Visethreach: Biomechanics Devi-Agri

From Dr. Wagner
Subject re:re:Shielding the nanobot
To ics.suipelcsA|LARRYNIVEN#ics.suipelcsA|LARRYNIVEN

There are some other advantages here as well, fluoridated bone is a highly magically conductive material. There is a reason that tea (which accumulates fluorine) was so prevalent amongst mystics of all types.

Dr. Wagner: Esoteric Materials, Berlin
It would be a scientifically interesting way to die screaming.


From Dr. Wong
Subject Scale concerns
To ics.suipelcsA|LARRYNIVEN#ics.suipelcsA|LARRYNIVEN

Not to hurt everyone's feelings, but if we want to fit in all of the features that this project will need, we end up with a superstructure that is far too large to be acceptable. It is a hard requirement that this nanobot can fit into the smallest blood vessels, which usually require red blood cells to line up one at a time. Unless we can fix this, we will need to significantly scale back the effectiveness of Nevinyrral.

Dr. Wong, nanomechanics, Peking University

From Dr. Liu
Subject re:Scale concerns
To ics.suipelcsA|LARRYNIVEN#ics.suipelcsA|LARRYNIVEN

Could we potentially use tiny atoms, see the attached paper. That would allow us to miniaturize the entire system with no loss of functionality.

Dr. Liu: Huo Hua Inc


1 Attachment:

From Dr. Wong
Subject re:re:Scale concerns
To ics.suipelcsA|LARRYNIVEN#ics.suipelcsA|LARRYNIVEN

I am going to ignore the filename there.

In any case, that paper was not replicable sadly.

Dr. Wong, nanomechanics, Peking University

From Dr. Liu
Subject re:re:re:Scale concerns
To ics.suipelcsA|LARRYNIVEN#ics.suipelcsA|LARRYNIVEN

Hrrm, how about using traditional shrinking technologies, derivatives of VNP-786 should work here. We will need to rework the binding system to attach to a relatively larger virus, however.

Dr. Liu: Vanguard Nanotech division, Lighthouse-52


From Dr. Small
Subject Congratulations everyone!
To ics.suipelcsA|LARRYNIVEN#ics.suipelcsA|LARRYNIVEN

We have a prototype for how to make a nanobot that can fight this virus. Now how do we manufacture it in large enough quantities to be useful? The people at the top banned us from making it self-replicating as they don't want what happened to Ceres to happen to Earth.

Dr. Small: Nanoforge, Lichtenstein
Big things are made of many small things

From Dr. Wong
Subject re:Congratulations everyone!
To Dr. Small

We are never going to live that down are we?

Dr. Wong, nanomechanics, Peking University

From Dr. Li
Subject Bacterial assembly
To ics.suipelcsA|LARRYNIVEN#ics.suipelcsA|LARRYNIVEN

How about assembling the system inside of a bacterial colony? These things are too large to assemble inside of bacteria unlike some of our older nanobots. So perhaps some kind of extracellular assembly system could work. I spun up EnzymeGPT and I do have a set of plasmids that can assemble all of the components, see attached for the proposed reaction pathways.

Dr. Li: Feng Huo technology


2 Attachments:

From Dr. Qin
Subject re:Bacterial assembly
To ics.suipelcsA|LARRYNIVEN#ics.suipelcsA|LARRYNIVEN

Problem, we will need to have all of these bacteria communicate as effectively as a superorganism. We could use a biofilm structure as a base. The system will need to start with a small number of bacteria arranged in a small group that slowly expands as the system gets bigger, as the final product before shrinking will be much larger than the bacteria on their own.

Dr. Qin: Shenzhen precise biology

From Dr. Li
Subject re:re:Bacterial assembly
To ics.suipelcsA|LARRYNIVEN#ics.suipelcsA|LARRYNIVEN

It turns out that this is very doable, I found a paper on the synthesis of diamonds that uses this method. Now our nanomachine is a lot more complicated, however, the hard work has already been done. Simple molecular clocks and elementary communication should allow us to start to manufacture this.

Dr. Li: Feng Huo technology


2 Attachments:


From Dr. Small
Subject Synthesis issues
To ics.suipelcsA|LARRYNIVEN#ics.suipelcsA|LARRYNIVEN

Alright, so we have inducted each of the component pathways into the bacteria. The following pathways have not produced usable outputs.

  • Synthesis of the macroantibodies
  • Synthesis of the peroxide generators

Dr. Small: Nanoforge, Lichtenstein
Big things are made of many small things

From Dr. Qin
Subject re:Synthesis issues
To ics.suipelcsA|LARRYNIVEN#ics.suipelcsA|LARRYNIVEN

This looks to be a folding problem. Regenerating the relevant enzyme sequence at a higher noise level should work there.

Dr. Qin: Shenzhen precise biology


From Dr. Small
Subject Total success!
To ics.suipelcsA|ERUC#ics.suipelcsA|ERUC

We have done it, we have constructed a nanobot that can counteract the virus. See the attached files.

The nanobots have been successful at stopping infection of class 3 thaumaturgically active mice! We have also not seen any significant negative side effects of this process, even with significant overdoses.

Some issues still need to be ironed out, but we are ready to go into large-scale testing and production now.

Dr. Small: Nanoforge, Lichtenstein
Big things are made of many small things


2 Attachments:

From Dr. Simon Torres
Subject re:Total success!
To ics.suipelcsA|ERUC#ics.suipelcsA|ERUC

Excellent. The Global Occult Coalition will be informed ASAP.
We may have just saved humanity.

Simon Torres, CEO of Phoenix Technologies
Icarus is not a story about the limitations of humanity
It is a story about the limitations of wax.


The New York Times.

All the news that's fit to print



From Dr. Small
Subject Let's cure this thing!
To ics.suipelcsA|GNIRUTCAFUNAM#ics.suipelcsA|GNIRUTCAFUNAM

Here are the plans and information on how to manufacture the Nevinyrral nanobot. It is now up to you people to mass manufacture this nanobot and distribute it.

Dr. Small: Nanoforge, Lichtenstein
Big things are made of many small things


From Dr. Kirsty
Subject The problems of scientific scaling
To ics.suipelcsA|GNIRUTCAFUNAM#ics.suipelcsA|GNIRUTCAFUNAM

What were the people who developed this procedure thinking?! Their method requires a decent-sized fermentation vat to produce singular doses of the nanobot, we need to figure out how to increase total production by two orders of magnitude before we have something that can be deployed on any sort of scale.

Dr. Kirsty: Synthitase biochemistry
Replicating a better world

From Jeff Davis
Subject re:The problems of scientific scaling
To ics.suipelcsA|GNIRUTCAFUNAM#ics.suipelcsA|GNIRUTCAFUNAM

Time to deploy the tiny bacterial whips I have been working on?

Jeff Davis: Synthitase biochemistry

From Dr. Kirsty
Subject re:re:The problems of scientific scaling
To ics.suipelcsA|GNIRUTCAFUNAM#ics.suipelcsA|GNIRUTCAFUNAM

This is no time to joke around.

Dr. Kirsty: Synthitase biochemistry
Replicating a better world

From Dr. Mohutsiwa
Subject Optimization of assembly
To ics.suipelcsA|GNIRUTCAFUNAM#ics.suipelcsA|GNIRUTCAFUNAM

By modification of the cluster's structure, internal communication, and some more specialization of labor we think we could get an order of magnitude faster than what we have been handed. What other options do we have here?

Dr. Mohutsiwa. Botswana Biochemistry

From Dr. Kirsty
Subject re:Optimization of assembly
To ics.suipelcsA|GNIRUTCAFUNAM#ics.suipelcsA|GNIRUTCAFUNAM

Could we try speeding up time inside of the vats? Additionally making the vats bigger on the inside.

Dr. Kirsty: Synthitase biochemistry
Replicating a better world

From Dr. Pule
Subject re:re:Optimization of assembly
To ics.suipelcsA|GNIRUTCAFUNAM#ics.suipelcsA|GNIRUTCAFUNAM

I had a chat with temporal mechanics and they say that is doable, though we will need to significantly redesign our vats to deal with the increase in waste heat as well as increased mass. I have put in an order with manufacturing.

Dr. Pule: YuanJi Incorporated.


1 Attachment:


From Zhang
Subject Major order of new Fermentation vats
To moc.ygoloiBoooS|LLA#moc.ygoloiBoooS|LLA

听好了伙计们,我们收到了新款纳米发酵缸的订单。生产流水线要007排班生产,我们所有人得尽快训练好发酵缸的新操作人员。不是每一天你会听到世界的命运依赖着我们,但今天这句话我是必须说的。我们人类需要这项发酵缸来阻止华盛顿纳米病毒。


Automatic Translation generated by LLaMa-7.1-400B

Alright, folks, we have a massive scale order of a new kind of fermentation vat. The assembly lines will be running 24/7 now, it will be everyone's job to train new workers on how to make these things as quickly as possible. It's not often we can say the fate of the world depends on our work, but currently, it does.

Zhang: Sooo Biological Manufacturing.


NPR

World News

Proposed impeachment of President Crenshaw fails 224-223

The impeachment failed by the slimmest of votes due to Megan McCain falling ill to the Washington Virion.


From Jeremy Johnston
Subject Distribution of the vaccine
To gro.nu.ophw|NORIV-NOTGNIHSAW#gro.nu.ophw|NORIV-NOTGNIHSAW

We have identified ideal locations for the manufacturing of this nanobot, namely easy logistical access and high local population densities, especially of anomalous beings. We have drafted up plans on how we can get this vaccine to the 11 billion people who need it.

PEPFAR and Operation Warp Speed provided a very useful set of guidelines here.

Jeremy Johnston. World Parahealth Organization


From Olivia Brown
Subject Scaling of the preventive system
To gro.nu.ophw|NORIV-NOTGNIHSAW#gro.nu.ophw|NORIV-NOTGNIHSAW

What exactly is the plan for spreading the externally applied nanobot? While we can inject people and captive anomalous entities with the nanomachines, we can't exactly do that with creatures in the wild.

Olivia Brown. World Parahealth Organization

From Jeremy Johnston
Subject re:Scaling of the preventative system
To gro.nu.ophw|NORIV-NOTGNIHSAW#gro.nu.ophw|NORIV-NOTGNIHSAW

The current plan is what New Zealand did to fight possums in the country before it sunk below the waves. Mass aerial spraying via helicopters and planes.

Jeremy Johnston. World Parahealth Organization


1 Attachment:

1080.jpg


Washington Post

Democracy Dies in Darkness

Washington

Oct 17rd, 2049

The nightmare is over!

Distribution of the Asclepius vaccine is in full swing


asterisk.png

2056: Stockholm, Sweden. 6 years after the crisis

Dr. Small walked onto the stage and shook hands with the Queen of Sweden. A prize named after a merchant of death was bestowed upon him for his work curing the greatest threat to the world as we know it since the Impasse.

"I would like to thank the Nobel Prize committee for this great honor. Of course, I cannot say that I was solely responsible for this great work. The Asclepius nanomachine and its many derivatives that have made life so much better for everyone was a massive collaboration between thousands of scientists. Every grand advance is built from many small ideas and minor innovations."

Dr. Small waved to the audience of scientists.

"The Asclepius nanomachine is quite frankly a scientific miracle. The Washington Viron was the result of decades of advances in biological warfare to create the most incurable epidemic possible. However, with the massive mobilization of the global scientific community spearheaded by Dr. Torres, we managed to create the miracle for ourselves. We reached for the heavens and grabbed what we could, pushing past the limits of what we thought to be possible."

He looked down at his carefully prepared speech, a lovely bit of PR by Nanoforge and Phoenix.

He decided to ignore it.

"However there is one major failure. While the scientific community created miracle after miracle fighting this virus, the rest of the world failed at it. Starting of course with Crenshaw creating this abominable virus to begin with. Though the man was very clear he was going to do something like this in the build-up to his election, we cannot lay the blame on one man's evil, but we need to look at the country itself. A nation so wrapped up in a fear of the other, that they are willing to elect anyone who claims they have a solution, no matter how evil or how unlikely it is to work.

"On the other hand, we have the UNGOC, whose response to this crisis, ended up causing yet more problems. The starting attempts to seal off the United States and various cities likely saved the world from a much worse fate. However, their actions afterward seemed to imply an organization more focused on its own power than on actually stopping the virus. Its heavy-handed actions inspired more resistance to the isolation needed to keep the virus contained, which ultimately led to the virus spreading more than it would have otherwise. The GOC treated this crisis as an opportunity to cover up their crimes in Silesia with good PR.

"Science saved us from this calamity, but it was a failure in the humanities that got us into this mess. We have a general public who is okay with othering a massive section of the population and a leadership that is more obsessed with power and revenge than any kind of ethics.

"Science bailed us out this time, but it may not in the future. The only way we can do that is by knowing each other better.

"Knowledge is power, but it is up to us to figure out how we use it."

Unless otherwise stated, the content of this page is licensed under Creative Commons Attribution-ShareAlike 3.0 License